1. Home
  2. EPAC vs ADPT Comparison

EPAC vs ADPT Comparison

Compare EPAC & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPAC
  • ADPT
  • Stock Information
  • Founded
  • EPAC 1910
  • ADPT 2009
  • Country
  • EPAC United States
  • ADPT United States
  • Employees
  • EPAC N/A
  • ADPT N/A
  • Industry
  • EPAC Industrial Machinery/Components
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EPAC Technology
  • ADPT Health Care
  • Exchange
  • EPAC Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • EPAC 2.0B
  • ADPT 1.8B
  • IPO Year
  • EPAC N/A
  • ADPT 2019
  • Fundamental
  • Price
  • EPAC $41.89
  • ADPT $12.85
  • Analyst Decision
  • EPAC Buy
  • ADPT Strong Buy
  • Analyst Count
  • EPAC 1
  • ADPT 8
  • Target Price
  • EPAC $53.00
  • ADPT $12.38
  • AVG Volume (30 Days)
  • EPAC 350.2K
  • ADPT 2.1M
  • Earning Date
  • EPAC 10-14-2025
  • ADPT 08-05-2025
  • Dividend Yield
  • EPAC 0.10%
  • ADPT N/A
  • EPS Growth
  • EPAC 7.49
  • ADPT N/A
  • EPS
  • EPAC 1.63
  • ADPT N/A
  • Revenue
  • EPAC $608,099,000.00
  • ADPT $205,216,000.00
  • Revenue This Year
  • EPAC $6.24
  • ADPT $32.76
  • Revenue Next Year
  • EPAC $5.86
  • ADPT $15.81
  • P/E Ratio
  • EPAC $25.72
  • ADPT N/A
  • Revenue Growth
  • EPAC 2.82
  • ADPT 21.60
  • 52 Week Low
  • EPAC $36.51
  • ADPT $3.98
  • 52 Week High
  • EPAC $51.91
  • ADPT $13.52
  • Technical
  • Relative Strength Index (RSI)
  • EPAC 53.19
  • ADPT 57.94
  • Support Level
  • EPAC $41.39
  • ADPT $12.62
  • Resistance Level
  • EPAC $42.94
  • ADPT $13.52
  • Average True Range (ATR)
  • EPAC 0.89
  • ADPT 0.54
  • MACD
  • EPAC -0.12
  • ADPT -0.03
  • Stochastic Oscillator
  • EPAC 18.34
  • ADPT 58.13

About EPAC Enerpac Tool Group Corp.

Enerpac Tool Group Corp provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company has one reportable segment, the Industrial Tools & Services (IT&S) Segment. The IT&S segment is engaged in the design, manufacture, and distribution of branded hydraulic and mechanical tools and in providing services and tool rental to the refinery/petrochemical; general industrial; industrial maintenance, repair, and operations (MRO); machining & manufacturing; power generation; infrastructure; mining; and other markets. Geographically, the company has operations in Algeria, Australia, Brazil, France, Germany, Kazakhstan, India, Italy, Japan, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, and the United Arab Emirates.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: